Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  125.00 3.13% 4,115.00 4,080.00 4,150.00 4,115.00 3,990.00 3,990.00 132,920 11:44:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.3 8.2 139.4 29.5 214

Bioventix Share Discussion Threads

Showing 1126 to 1148 of 1475 messages
Chat Pages: Latest  47  46  45  44  43  42  41  40  39  38  37  36  Older
DateSubjectAuthorDiscuss
24/10/2019
11:16
18 quid John? You were saying 10 a couple of days ago. That's quite a turnaround. Are you a politician?
stepone68
24/10/2019
11:15
Span - I already did buy back in, unfortunately before the current price drop :-(
stepone68
24/10/2019
10:39
dead cat bounce
the cat is dead

long live the cat

heading tio 18 quid

onjohn
24/10/2019
10:38
"An expert in chart analysis" Love it, they're like experts in astrology.
trident5
24/10/2019
10:21
Possibly a Long way to fall then as profits have increased just 1%? Maybe he’s right
toptrump1
24/10/2019
10:20
Oh no, not a "death cross". We're all doomed!

@StepOne, as someone who also reduced this year, are you like I am looking at this thinking about buying back in if it gets much lower? At what price if any would you consider a repurchase? Cheers.

spann_703
24/10/2019
10:08
Can you post his analysis from April 2018? See if he predicted share price doubling in 12 months.

Thanks,
StepOne

stepone68
24/10/2019
09:54
From an expert in chart analysis:

BVXP
Death cross 23/10/2019
There are longer term H&S/BARF patterns, but the recent development is a bearish flag.
This confirms with an eod close below approx 3050. Tp approx 2670

The historical support centred around 3000 really has to hold.

There is a potential turn 25/10/2019

toptrump1
22/10/2019
21:53
Finally someone (Biogen) has shown that targetting amyloid clinically with antibodies as a drug successfully treats the Alzheimer's disease. This is very promising for Bioventix colloboration with pre-diagnostics and their diagnostic antibodies to amyloid.

It proves amyloid is a valid target to use for monitoring the disease.

https://www.bbc.co.uk/news/health-50137041

johnsmith321
22/10/2019
13:05
Hi trident5,

..."ONJohn is giving us plenty to digest...."

From his perspective of self-confessed ignorance, too...;->

Truly, we are blessed.

ATB

extrader
22/10/2019
12:31
It is an AIM stock - yes. Has your research thrown up any other helpful insights you could share with us? Not to worry if not, as ONJohn is giving us plenty to digest.
trident5
22/10/2019
12:19
This is an AIM stock isn’t it? and as we know when they go down they really go down, shouldn’t worry too much with their impressive track record to date IMHO.
luderitz
22/10/2019
10:27
£10 seems unlikely. Single figures P/E with a yield over 10% and Troponin growth about to start coming through.

Can't disagree with the first part of your sentence though :-)

stepone68
22/10/2019
10:21
My charting skills are non-existent, but £10 even possible as in freefall, cant see a recovery for any reason
onjohn
22/10/2019
10:18
down down deeper and down


status quo



Just sayin


18 quid could be comung

onjohn
22/10/2019
07:21
Ta muchly Boros10.

Just from the tone of the medical articles about hs-troponin introduction and the associated protocols I expect them to beat the finnCap estimates. I had not understood that BVXP would be responsible for the pollution diagnostic. I guess/hope production and distribution will be farmed out.

apad

apad
22/10/2019
06:33
Freely available (subject to registration) FinnCap report here: Https://researchlibrary.finncap.com/File/View?file=891f2918-0f61-4737-955c-432b2ac13af5
carcosa
21/10/2019
23:17
I'm sorry about earlier. Someone contacted me via twitter and I thought it was you so gave them the call details. I couldn't find your message via ADVFN. The meeting was very positive. Management appear very confident of hitting finnCap's Troponin forecast of £500k in the current year and £1.1m next. They also seem very hopeful on the prospects for the pollution diagnostic. I got the impression they have made very good progress in developing the antibody or antibodies required but their thinking about how to manufacturer the diagnostic and the route to market are less advanced. It would be the first time that Bioventix has created a diagnostic. They believe customers would include research institutions and members of the public. One key positive is that FDA approval would not be required to launch the test.
boros10
21/10/2019
18:56
Any feedback from the Finncap meeting, Leon?
apad

apad
21/10/2019
13:39
What is the PE here. Looks a bit high to me.
nobilis
21/10/2019
13:28
Courtesy of bamboo on another thread, I think this has further to fall

BVXP, has historical support at 3150, 2990
Chart shows confirmed H&S [3000] and BARF [3200] patterns.

Potential turns 21/10 & 7/11/2019
Trades also on NEX:BVXP.GB

toptrump1
21/10/2019
13:15
Smells like Sheep dip
onjohn
21/10/2019
13:11
Leon,
Sent you an advfn message, twitter wouldn't let me message you 😊 You're obviously exalted!
apad

apad
Chat Pages: Latest  47  46  45  44  43  42  41  40  39  38  37  36  Older
Your Recent History
LSE
BVXP
Bioventix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230201 05:59:48